Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002041229 | SCV002312177 | uncertain significance | Fanconi anemia complementation group O | 2021-07-06 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with RAD51C-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant is not present in population databases (ExAC no frequency). This sequence change replaces methionine with valine at codon 118 of the RAD51C protein (p.Met118Val). The methionine residue is weakly conserved and there is a small physicochemical difference between methionine and valine. |
Fulgent Genetics, |
RCV002492386 | SCV002775994 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 3; Fanconi anemia complementation group O | 2022-05-25 | criteria provided, single submitter | clinical testing |